The value of research for ERCC1 expression testing to inform adjuvant chemotherapy decisions in resected Stage II non-small cell lung cancer.

J. Roth, J. Carlson, Lotte Maria Gertruda Steuten, S. Ramsey, D. Veenstra

    Research output: Contribution to conferencePaper

    Original languageEnglish
    Pages-
    Publication statusPublished - 22 Oct 2011
    Event33rd Annual Meeting of the Society for Medical Decision Making, SMDM 2011: From Evidence to Decision Making: Role of Behavioral Economics in Medicine - Chicago, United States
    Duration: 22 Oct 201126 Oct 2011
    Conference number: 33
    http://smdm.org/meeting/33rd-annual-north-american-meeting

    Conference

    Conference33rd Annual Meeting of the Society for Medical Decision Making, SMDM 2011
    Abbreviated titleSMDM
    CountryUnited States
    CityChicago
    Period22/10/1126/10/11
    Internet address

    Keywords

    • METIS-284447

    Cite this

    Roth, J., Carlson, J., Steuten, L. M. G., Ramsey, S., & Veenstra, D. (2011). The value of research for ERCC1 expression testing to inform adjuvant chemotherapy decisions in resected Stage II non-small cell lung cancer.. -. Paper presented at 33rd Annual Meeting of the Society for Medical Decision Making, SMDM 2011, Chicago, United States.